NeuroBo Pharmaceuticals, Inc. Expands Scientific Advisory Board with Appointment of Danamarie Belpulsi, M.D.

/PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company, today announced the appointment, effective immediately,...

Related Keywords

Boston ,Massachusetts ,United States ,London ,City Of ,United Kingdom ,Danamarie Belpulsi ,Michael Miller ,King College London ,Juniper Pharmaceuticals ,York University College Of Arts ,Rx Communications Group ,International American University College Of Medicine ,Nasdaq ,Prnewswire Neurobo Pharmaceuticals Inc ,Neurobo Pharmaceuticals Inc ,Enkefalos Research ,Catalent Inc ,King College ,Securities Exchange ,College Of Arts ,School Of Medical Education ,Scientific Advisory ,Gil Price ,Chief Executive Officer ,Scientific Advisory Board ,Medical Director ,Drug Safety Solution ,Medical Monitoring ,Cell Biology ,Columbia University Medical Center College ,Verseau Therapeutics ,Medical Sciences ,International American University College ,College London ,Post Baccalaureate ,Pre Clinical Medicine ,New York University ,Private Securities Litigation Reform Act ,Securities Exchange Act ,Neurobo Pharmaceuticals ,Nc ,